Certuity’s Biogen BIIB Stock Holding History

Certuity’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-947	Closed	-$245K	–	336
2023 Q4	$245K	Buy	947 +32	+3%	+$7.86K	0.02%	281
2023 Q3	$233K	Buy	915 +18	+2%	+$4.81K	0.03%	228
2023 Q2	$253K	Buy	+897	New	+$267K	0.03%	223
2021 Q3	–	Sell	-642	Closed	-$222K	–	404
2021 Q2	$222K	Buy	+642	New	+$194K	0.05%	297

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Certuity's BIIB Position: Q1 2024 in Review

Certuity sold out of Biogen (BIIB) in Q1 2024, closing a stake of 947 shares — an estimated $245K sold.

Certuity first reported a position in BIIB in Q2 2021 and held it in 4 quarters. The position peaked at $253K in Q2 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Certuity reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
Certuity sold 947 Biogen shares in Q1 2024, an estimated $245K.
Certuity first reported a position in Biogen in Q2 2021 and held it in 4 quarters.
Certuity's Biogen position peaked at $253K in Q2 2023.
954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Certuity's 13F filing for Q1 2024, filed 15 May 2024.